Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Me
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures tumble as Amazon, Intel results deepen AI spending woes
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
| (NASDAQ: NVCR) | Delayed: 13.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.11 | 52 Week High | $28.95 | |||
| Open | $13.11 | 52 Week Low | $5.95 | |||
| Day High | $13.11 | P/E | N/A | |||
| Day Low | $13.11 | EPS | $0.00 | |||
| Volume | 122 | |||||
| (NASDAQ: ZLAB) | Delayed: 22.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.36 | 52 Week High | $ | |||
| Open | $22.36 | 52 Week Low | $ | |||
| Day High | $22.36 | P/E | N/A | |||
| Day Low | $22.36 | EPS | $ | |||
| Volume | 20,026 | |||||
